Affiliation:
1. Department of New Lead Discovery, Schering-Plough Research Institute, Kenilworth, NJ
Abstract
Kinases are an important therapeutic target for drug discovery, and many cancer chemotherapeutic agents have been derived from natural product sources. Natural product samples, however, have the likelihood of assay interference, particularly at elevated test concentrations. The authors developed a competitive fluorescence polarization (FP) assay using red-shifted fluorophores for the AKT kinase and demonstrated utility for testing concentrated natural product extracts. A set of 7 actinomycetes cultures containing indolocarbazoles, known nonselective kinase inhibitors, and a control set of 22 nonproducing indolocarbazole cultures were evaluated. Using red-shifted dyes (Cy3B™ or Cy5™), the authors identified active samples with minimal interference up to the extract concentrations that are 3 times nonextracted culture levels. In contrast, a significant number of interferences were observed using either a fluorescein competitive FP assay or a [33P]ATP Flashplate assay. This work demonstrates that one can screen natural product extracts at high concentrations successfully using FP technology with red-shifted dyes. ( Journal of Biomolecular Screening 2004:52-61)
Reference39 articles.
1. 1. Fabbro D, Garcia-Echeverria C: Targeting protein kinases in cancer therapy . Curr Opin Drug Discov Dev 2002;5: 701-712 .
2. 2. Orchard S: Kinases as targets: prospects for chronic therapy . Curr Opin Drug Discov Dev 2002;5: 713-717 .
3. Tyrosine kinase inhibitors: From rational design to clinical trials
4. Imatinib mesylate (Gleevec(R)/Glivec(R)): A new therapy for chronic myeloid leukemia and other malignancies
5. 5. Zimmermann J: Glivec: a new treatment modality for CML: a case history . Chimia 2002;56: 428-431 .
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献